Vimarsana
Biggest News Aggregation in the World

Page 2 - Arthur Rouill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arthur Rouill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arthur Rouill Today - Breaking & Trending Today

Report of the ICAPE Group's Combined General Meeting Held on May 22, 2024 - Vimarsana News

Report of the ICAPE Group's Combined General Meeting Held on May 22, 2024

Regulatory News: The ICAPE Group (ISIN code: FR001400A3Q3 Ticker: ALICA), a global technology distributor of printed circuit boards ("PCB") and custom-made electromechanical parts, announces that

Innate Pharma SA: Innate Pharma: Clarification Regarding SAR443579 Designation - Vimarsana News

Innate Pharma SA: Innate Pharma: Clarification Regarding SAR443579 Designation

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that in an abstract published on 14 May 2024 for the European Hematology Association

Medincell to Present at the 2024 Jefferies Global Healthcare Conference, June 4 to 6, 2024, New York - Vimarsana News

Medincell to Present at the 2024 Jefferies Global Healthcare Conference, June 4 to 6, 2024, New York

Regulatory News: Medincell (Paris:MEDCL): Christophe Douat, CEO, and Richard Malamut, CMO, will present Medincell's portfolio and R&D pipeline at the Jefferies Global Healthcare Conference on

TME Pharma N : receives US FDA Fast Track designation for lead asset NOX-A12 in brain cancer -April 02, 2024 at 02:40 pm EDT - Vimarsana News

TME Pharma N : receives US FDA Fast Track designation for lead asset NOX-A12 in brain cancer -April 02, 2024 at 02:40 pm EDT

TME PHARMA RECEIVES US FDA FAST TRACK DESIGNATION FOR LEAD ASSET NOX-A12 IN BRAIN CANCER Fast Track designation awarded by the...

TME Pharma N : Inside Information / Other news releases -April 02, 2024 at 05:16 pm EDT - Vimarsana News

TME Pharma N : Inside Information / Other news releases -April 02, 2024 at 05:16 pm EDT

TME PHARMA RECEIVES US FDA FAST TRACK DESIGNATION FOR LEAD ASSET NOX-A12 IN BRAIN CANCER Fast Track designation awarded by the...